Bristol-Myers Squibb Company
Cyclic dinucleotides as anticancer agents

Abstract:

The present invention is directed to compounds of the formula (I) wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders. ##STR00001##